imb-1018972
Showing 1 - 4 of 4
Type 2 Diabetes, Diabetic Cardiomyopathies, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Oxford (IMB-1018972)
Recruiting
- Type 2 Diabetes
- +2 more
- IMB-1018972
-
Oxford, United KingdomOxford University Hospital
Jan 9, 2023
Ischemia, Coronary Artery Disease Trial in Aarhus, Turku, Uppsala (IMB-1018972, Placebo)
Recruiting
- Ischemia
- Coronary Artery Disease
- IMB-1018972
- Placebo
-
Aarhus, Denmark
- +2 more
Nov 1, 2022
Non-obstructive Hypertrophic Cardiomyopathy Trial in United Kingdom, United States (IMB-1018972, Placebo)
Recruiting
- Non-obstructive Hypertrophic Cardiomyopathy
- IMB-1018972
- Placebo
-
La Jolla, California
- +13 more
Oct 11, 2022
Refractory Angina Trial (IMB-1018972, Placebo oral tablet)
Not yet recruiting
- Refractory Angina
- IMB-1018972
- Placebo oral tablet
- (no location specified)
May 29, 2020